Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats

European Surgical Research

Volumn 28, Issue 5, 1996, Pages 351-360

  Rosman, C ^a   Westerveld, G J ^a   Bleichrodt, R P ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Public Health Service of Groningen   (Netherlands)

^c TWENTEBORG HOSPITAL   (Netherlands)

Author keywords

Antibiotic; Bacteria; Endotoxin; Peritonitis; Taurolidine; Tumor necrosis factor

Indexed keywords

ANTIINFECTIVE AGENT; ENDOTOXIN; IMIPENEM; TAUROLIDINE; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

EID: 0029792352     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129476     Document Type: Article

References (31)

1. Dominioni L, Dionigi R, Zanello M, et al: Effcets of high-dose IgG on survival of surgical patients with sepsis score of 20 or greater. Arch Surg 1991;126:236-240.
2. Noon GP, Beall AC, Jordan GL, Stuart R, De Bakey ME: Clinical evaluation of peritoneal irrigation with antibiotic solution. Surgery 1967:62:73-78.
3. Hau T, Nishilawa R, Phuangsab A: Irrigation of the peritoneal cavity and local antibiotics in the treatment of peritonitis. Surg Gynecol Obstet 1983:156:25-30.
4. Edmiston CE, Goheen MP, Komhall S, Jones EE, Condon RE: Fecal peritonitis: Microbial adherence to serosal mesolhelium and resistance to peritoneal lavage. World J Surg 1990;14:176-183.
5. Stewart DJ, Matheson NA: Peritoneallavage in faecal peritonitis in the rat. Br J Surg 1978:65:57-59.
6. Rambo WM: Irrigation of the peritoneal cavity with cephalothin. Am J Surg 1972:123:192-195.
7. Nomikos IN, Kalsouyanni K, Papaioannou AN: Washing with or w'ithout chloramphenicol in the treatment of peritonitis: A prospective, clinical trial. Surgery 1986:99: 20-25.
8. Flint LM Jr., Beasly DJ, Richardson JD, Polk HC: Topical povidonc-iodine reduces mortality from bacterial peritonitis. J Surg Res 1979;26: 280-284.
9. Sindelar WF, Mason GF: Intraperitoneal irrigation with povidone iodine solution for the prevention of intra-abdominal abscess in the bacterially contaminated abdomen. Surg Gynecol Obstet 1979:148:409-411.
10. Browne MK, MacKenzie M, Doyle PJ: A controlled trial of taurolin in established bacterial peritonitis. Surg Gynecol Obstet 1978:146:721-724.
11. Platt J. Jones RA, Bueknall RA: In-trapcritoncal antiseptics in experimental bacterial peritonitis. Br J Surg 1984;71:626-628.
12. Vallance S, Waldron R: Antiseptics versus saline lavage in purulent and fecal peritonitis. J Hosp Infect 1985; 6:87-91.
13. Lawson KJ, Lavery I: Hydrogen peroxide versus normal saline lavage in experimental fecal peritonitis. Cleve Clin J Med 1987:54:279-284.
14. Görtz G, Häring R, Wicki O: Die antiseptische Lokalbehandlung der diffusen Peritonitis. Helv Chir Acta 1983;50:161-165.
15. Kuypers HC: Is prophylactic irrigation with polyvinylpyrrolidone iodine (PVP1) safe? Dis Colon Rectum 1985;28:481-483.
16. Schneider RK, Meyer DL, Embertson RM, Gentile DG, Buergelt CD: Response of pony peritoneum to four peritoneal lavage solutions. Am J Vet Res 1988;49:889-894.
17. Divincenti FC, Cohn I: Intraperito-neal kanamycin in advanced peritonitis. Aust NZ J Surg 1966:11:147-153.
18. Washington BC, Villalba MR, Lauter CB: Cefamandole-erythromycin-heparin peritoneal irrigation: An adjunct to the surgical treatment of diffuse bacterial peritonitis. Surgery 1983;94:576-581.
19. McCartney AC, Browne MK: Clinical studies on administration of taurolin in severe sepsis: A preliminary study: in Levin J, Bullen HR, ten Cate JW, van Deventer SJH, Sturk A (eds): Bacterial Endotoxins: Pathophysiological Effects, Clinical Significance and Pharmacological Control. New York. Liss. 1988. pp 361-371.
20. Browne MK, Leslie GB, Pfirrmann RW, Brodhage H: The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms. Surg Gvnccol Obstet 1977:145:842-846.
21. Pfirrmann RW: Taurolin - Ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen; Einführung und Übersieht: in Brückner WL, Pfirrmann RW (eds): Taurolin - Ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen. Munich. Urban & Schwarzenberg. 1985, pp 3-23.
22. Thomas LLM, Sturk A, Buller HR, Joop K, ten Cate JW: The in vitro inactivation of endotoxins by Taurolin; in Brückner WL. Pfirrmann RW (eds): Taurolin - Ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen. Munich. Urban & Schwarzenberg, 1985, pp 78-81.
23. Bedrosian I, Duane Sofia R, WollT SM, Dinarcllo CA: Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human periperal blood mononuclear cells. Cytokine 1991;3:568-575.
24. DofTerhofs ASM, Essclink MT, de Vries-Hospers HG, et al: The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 1993; 31:373-384.
25. Sturk A, Janssen MF, Muylaert FR, Joop K, Thomas LLM, ten Cate JW: Endotoxin testing in blood: in Watson SW. Levin J, Novitsky TJ (eds): Detection of Bacterial Endotoxin with the Limulus Amocbocyte Lysate Test. New York. Liss. 1987. pp 371-385.
26. Erb FN, Febvay M, Imbenotte M: Structural investigation of a new organic antimicrobial - Taurolidine. A spectroscopic study of its stability and equilibria in various solvents. Talanta 1982:29:953-958.
27. Waser PG, Sibler E, Ganz AJ: Pharmakologie und Toxikologie von Taurolidin; in Brückner WL. Pfirrmann RW (eds): Taurolin - Ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen. Munich, Urban & Schwarzenberg. 1985. pp 24-37.
28. Browne MK, Leslie GB, Pfirrmann RW: A comparison of noxythioline and povidonc-iodinc in experimentally induced peritoneal infection in mice. Br J Surg 1978:65:601-602.
29. Steibach-Lebbin C, Ganz AJ, Chang A, Waser PG: Über die Pharmakokinetik von Taurolin. Arzeimittel-forschung 1982:32:1542.
30. Pfirrmann RW: The anti-endotoxic activity of taurolin in experimental animals. J Appl Bacteriol 1979:46: 97-102.
31. Tracey KJ, Lowry SF: The role of cytokine mediators in septic shock. Adv Surg 1990;23:21-56.